Investigational Weight Loss Medication
Retatrutide
Retatrutide is one of the most talked-about investigational weight loss medications. While it is not currently FDA-approved or available as a prescription treatment. Any information about Retatrutide is for educational purposes only.
What Is Retatrutide?
Retatrutide is an investigational injectable medication being studied for weight loss and metabolic health. It is often discussed as a “triple agonist” because it targets GLP-1, GIP, and glucagon receptors. These pathways are involved in appetite, blood sugar regulation, energy balance, and weight management.
Although early clinical trial results have created major interest, Retatrutide is not currently FDA-approved for weight loss and is not commercially available as a standard prescription medication.
Medication Weight Loss Options in Jupiter, FL
Jupiter Weight Loss has many medical weight loss options. Our providers can help determine which treatment may be appropriate based on your health history, goals, BMI, medications, and provider evaluation.
Tirzepatide
Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. It works on GLP-1 and GIP pathways and is commonly used in provider-supervised weight loss programs.
Learn About Tirzepatide →Semaglutide
Semaglutide is the active ingredient in Wegovy® and Ozempic®. It is a GLP-1 medication option used to support appetite control and weight loss.
Learn About Semaglutide →Zepbound® & Mounjaro®
Patients searching for the newest injectable weight loss options often ask about Zepbound® and Mounjaro®, both related to tirzepatide treatment.
View Zepbound® & Mounjaro® →Wegovy® & Ozempic®
Wegovy® and Ozempic® are well-known semaglutide-based medications often discussed by patients researching GLP-1 weight loss options.
View Wegovy® & Ozempic® →Retatrutide vs. Tirzepatide vs. Semaglutide
Retatrutide is being studied as a triple-receptor medication, while tirzepatide works on GLP-1 and GIP pathways and semaglutide works primarily through GLP-1. Because Retatrutide is still investigational, it is not available to patients and is not offered at Jupiter Weight Loss. Any information on retatrutide is for educational purposes only. Patients interested in medical weight loss have options such as tirzepatide or semaglutide. The right option depends on your medical history, weight loss goals, tolerance, provider recommendations, and availability.
Frequently Asked Questions About Retatrutide
Is Retatrutide FDA-approved?
No. Retatrutide is currently investigational and is not FDA-approved as a commercially available weight loss medication. It is not abvuilable nor offered at Jupiter Weight Loss.
Can I get Retatrutide at Jupiter Weight Loss?
No. We do not offer Retatrutide because it is not currently FDA-approved or commercially available. We do offer provider-supervised alternatives such as semaglutide and tirzepatide.
What are the best alternatives to Retatrutide right now?
Common alternatives patients ask about include tirzepatide, semaglutide, Zepbound®, Mounjaro®, Wegovy®, and Ozempic®, depending on medical eligibility and provider recommendation.
How do I know which weight loss medication is right for me?
The best way to determine your options is to schedule a provider consultation. Your provider can review your health history, goals, medications, and eligibility.
Schedule Your Medical Weight Loss Appointment Online
Jupiter Weight Loss offers physician-supervised medical weight loss options.
Book Your Consultation